← Evidence map

ArticleThe World Allergy Organization journal2024

Erratum to "Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD" [World Allergy Organ (2023) 100817].

Fatma Merve Tepetam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Erratum to "Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD" [World Allergy Organ (2023) 100817]. | OpenQuestion